Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

383 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Non-suppressible viraemia during HIV-1 therapy: a challenge for clinicians.
Esteban-Cantos A, Montejano R, Pinto-Martínez A, Rodríguez-Centeno J, Pulido F, Arribas JR. Esteban-Cantos A, et al. Among authors: arribas jr. Lancet HIV. 2024 May;11(5):e333-e340. doi: 10.1016/S2352-3018(24)00063-8. Epub 2024 Apr 8. Lancet HIV. 2024. PMID: 38604202 Review.
New Strategies of ARV: the Road to Simplification.
de Miguel Buckley R, Montejano R, Stella-Ascariz N, Arribas JR. de Miguel Buckley R, et al. Among authors: arribas jr. Curr HIV/AIDS Rep. 2018 Feb;15(1):11-19. doi: 10.1007/s11904-018-0371-6. Curr HIV/AIDS Rep. 2018. PMID: 29353398 Review.
Epigenetic age acceleration changes 2 years after antiretroviral therapy initiation in adults with HIV: a substudy of the NEAT001/ANRS143 randomised trial.
Esteban-Cantos A, Rodríguez-Centeno J, Barruz P, Alejos B, Saiz-Medrano G, Nevado J, Martin A, Gayá F, De Miguel R, Bernardino JI, Montejano R, Mena-Garay B, Cadiñanos J, Florence E, Mulcahy F, Banhegyi D, Antinori A, Pozniak A, Wallet C, Raffi F, Rodés B, Arribas JR; NEAT001/ANRS143 Study Group. Esteban-Cantos A, et al. Among authors: arribas jr. Lancet HIV. 2021 Apr;8(4):e197-e205. doi: 10.1016/S2352-3018(21)00006-0. Lancet HIV. 2021. PMID: 33794182
Longitudinal Changes in Epigenetic Age Acceleration in Aviremic Human Immunodeficiency Virus-Infected Recipients of Long-term Antiretroviral Treatment.
Esteban-Cantos A, Montejano R, Rodríguez-Centeno J, Saiz-Medrano G, De Miguel R, Barruz P, Bernardino JI, Mena-Garay B, Cadiñanos J, Jiménez-González M, Nevado J, Valencia E, Mayoral-Muñoz M, Arribas JR, Rodés B. Esteban-Cantos A, et al. Among authors: arribas jr. J Infect Dis. 2022 Jan 18;225(2):287-294. doi: 10.1093/infdis/jiab338. J Infect Dis. 2022. PMID: 34166509
COVID-19 in hospitalized HIV-positive and HIV-negative patients: A matched study.
Díez C, Del Romero-Raposo J, Mican R, López JC, Blanco JR, Calzado S, Samperiz G, Portilla J, García-Fraile LJ, Gutiérrez F, Gómez-Sirvent JL, Suárez-García I, Amador C, Novella M, Arribas JR, Moreno S, González-García J, Jarrín I, Berenguer J; for CoRIS. Díez C, et al. Among authors: arribas jr. HIV Med. 2021 Oct;22(9):867-876. doi: 10.1111/hiv.13145. Epub 2021 Jul 29. HIV Med. 2021. PMID: 34324783 Free PMC article.
Treatment of advanced HIV infection.
Pulido F, Arribas JR. Pulido F, et al. Among authors: arribas jr. J Antimicrob Chemother. 2003 Feb;51(2):225-7. doi: 10.1093/jac/dkg065. J Antimicrob Chemother. 2003. PMID: 12562685 Review. No abstract available.
A safety evaluation of raltegravir for the treatment of HIV.
de Miguel R, Montejano R, Stella-Ascariz N, Arribas JR. de Miguel R, et al. Among authors: arribas jr. Expert Opin Drug Saf. 2018 Feb;17(2):217-223. doi: 10.1080/14740338.2018.1411903. Epub 2017 Dec 5. Expert Opin Drug Saf. 2018. PMID: 29199485 Review.
Impact of Nucleos(t)ide Reverse Transcriptase Inhibitors on Blood Telomere Length Changes in a Prospective Cohort of Aviremic HIV-Infected Adults.
Montejano R, Stella-Ascariz N, Monge S, Bernardino JI, Pérez-Valero I, Montes ML, Valencia E, Martín-Carbonero L, Moreno V, González-Garcia J, Rodriguez-Centeno J, Rodes B, Cantos AE, Alejos B, de Miguel R, Arnalich F, Perona R, Arribas JR. Montejano R, et al. Among authors: arribas jr. J Infect Dis. 2018 Oct 5;218(10):1531-1540. doi: 10.1093/infdis/jiy364. J Infect Dis. 2018. PMID: 29912427
Risks and benefits of reducing the number of drugs to treat HIV-1 infection.
Cadiñanos J, Montejano R, de Miguel Buckley R, Marcelo C, Arribas JR. Cadiñanos J, et al. Among authors: arribas jr. Expert Opin Drug Saf. 2021 Apr;20(4):397-409. doi: 10.1080/14740338.2021.1887135. Epub 2021 Feb 24. Expert Opin Drug Saf. 2021. PMID: 33557651 Review.
383 results